// COMPANY
Marrow Therapeutics
SECTOR BIOTECHMENTIONS 1LAST SEEN NOVEMBER 19, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·StrictlyVC·NOVEMBER 19, 2026
“Marrow Therapeutics... develops injectable medicines that deliver RNA therapies to bone marrow cells to treat severe blood disorders, raised a combined $173 million across Series A and Series B rounds”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.